Acadia Pharmaceuticals | ACAD - Capital De Préstamo

Precio De Mercado
20.73
Cambio Diario
0.01 0.05%
Mensual
-16.17%
Anual
23.47%
Q1 Expectativa
19.99




Capital De Préstamo Cambio Fecha
Acadia Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 285.82M 639K 2024-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Cara Therapeutics USD 0 0 2025-03
Cytokinetics USD 1.12B 957.23M 2025-12
Eisai JPY 134.77B 12M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Incyte USD 30.2M 5.17M 2025-12
J&J USD 39.44B 30M 2025-12
Moderna USD 610M 584M 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pfizer USD 57.41B 93M 2025-09
Prothena USD 0 0 2024-12
PTC Therapeutics USD 2.03B 193.22M 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03